Lifetime costs and health outcomes of each strategy using a societal perspective
| Options . | Costs (BTN) . | Incremental LYs . | Incremental DALYs averted . | ICER (BTN per DALY averted) . |
|---|---|---|---|---|
| No screening | 210 023 | – | – | – |
| Current PEN program | 205 735 | 0.018 | 0.038 | −112 906 |
| Universal screening | 203 897 | 0.008 | 0.016 | −112 906 |
| Options . | Costs (BTN) . | Incremental LYs . | Incremental DALYs averted . | ICER (BTN per DALY averted) . |
|---|---|---|---|---|
| No screening | 210 023 | – | – | – |
| Current PEN program | 205 735 | 0.018 | 0.038 | −112 906 |
| Universal screening | 203 897 | 0.008 | 0.016 | −112 906 |
BTN, Bhutanese Ngultrum (value as of 2013); DALYs, disability adjusted life years; ICER, incremental cost-effectiveness ratio; LYs, life years.
Lifetime costs and health outcomes of each strategy using a societal perspective
| Options . | Costs (BTN) . | Incremental LYs . | Incremental DALYs averted . | ICER (BTN per DALY averted) . |
|---|---|---|---|---|
| No screening | 210 023 | – | – | – |
| Current PEN program | 205 735 | 0.018 | 0.038 | −112 906 |
| Universal screening | 203 897 | 0.008 | 0.016 | −112 906 |
| Options . | Costs (BTN) . | Incremental LYs . | Incremental DALYs averted . | ICER (BTN per DALY averted) . |
|---|---|---|---|---|
| No screening | 210 023 | – | – | – |
| Current PEN program | 205 735 | 0.018 | 0.038 | −112 906 |
| Universal screening | 203 897 | 0.008 | 0.016 | −112 906 |
BTN, Bhutanese Ngultrum (value as of 2013); DALYs, disability adjusted life years; ICER, incremental cost-effectiveness ratio; LYs, life years.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
